Observations that engineered HLA‐I‐restricted CD4+ T cells could directly kill peptide‐pulsed or tumour targets have been reported previously, but the mechanism of target cell killing varies across studies 17, 18, 19, 21, 41. This evidence concerns the gene CD4 and neoplasm.